Clinical trials
Phase 2 Immune System Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 2 |
| 2016 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
| Completed | 6 |
| Recruiting | 3 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cogent Biosciences, Inc. | 2 |
| GlaxoSmithKline | 2 |
| Inmagene LLC | 2 |
| Altair Therapeutics, Inc. | 1 |
| Amgen | 1 |
| Anelixis Therapeutics, LLC | 1 |
| AstraZeneca | 1 |
| Canadian Myeloma Research Group | 1 |
| Eli Lilly and Company | 1 |
| Gilead Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 21 |
| Skin Diseases | 6 |
| Dermatitis | 5 |
| Dermatitis, Atopic | 5 |
| Eczema | 5 |
| Hypersensitivity | 5 |
| Autoimmune Diseases | 4 |
| Neoplasms | 4 |
| Hematologic Diseases | 3 |
| Hypersensitivity, Immediate | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.